Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

AKT pathway genes define 5 prognostic subgroups in glioblastoma.

Joy A, Ramesh A, Smirnov I, Reiser M, Misra A, Shapiro WR, Mills GB, Kim S, Feuerstein BG.

PLoS One. 2014 Jul 1;9(7):e100827. doi: 10.1371/journal.pone.0100827. eCollection 2014.

2.

Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.

Hu LS, Eschbacher JM, Heiserman JE, Dueck AC, Shapiro WR, Liu S, Karis JP, Smith KA, Coons SW, Nakaji P, Spetzler RF, Feuerstein BG, Debbins J, Baxter LC.

Neuro Oncol. 2012 Jul;14(7):919-30. doi: 10.1093/neuonc/nos112. Epub 2012 May 3.

3.

Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.

Sankar T, Moore NZ, Johnson J, Ashby LS, Scheck AC, Shapiro WR, Smith KA, Spetzler RF, Preul MC.

J Neurosurg. 2012 Jun;116(6):1172-81. doi: 10.3171/2012.2.JNS102032. Epub 2012 Mar 16.

PMID:
22424566
4.

Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.

Hu LS, Eschbacher JM, Dueck AC, Heiserman JE, Liu S, Karis JP, Smith KA, Shapiro WR, Pinnaduwage DS, Coons SW, Nakaji P, Debbins J, Feuerstein BG, Baxter LC.

AJNR Am J Neuroradiol. 2012 Jan;33(1):69-76. doi: 10.3174/ajnr.A2743. Epub 2011 Nov 17.

5.

Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Bassig BA, Inskip PD, Burdette L, Shapiro WR, Selker RG, Fine HA, Loeffler JS, Black PM, Dubrow R, Brenner AV.

J Neuroimmunol. 2011 Apr;233(1-2):185-91. doi: 10.1016/j.jneuroim.2010.11.005. Epub 2010 Dec 30.

6.

DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.

Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Rothman N, Linet MS, Inskip PD.

Neuro Oncol. 2010 Jan;12(1):37-48. doi: 10.1093/neuonc/nop012. Epub 2009 Dec 10.

7.

Treatment modalities for leptomeningeal metastases.

Shapiro WR, Johanson CE, Boogerd W.

Semin Oncol. 2009 Aug;36(4 Suppl 2):S46-54. doi: 10.1053/j.seminoncol.2009.05.006. Review.

PMID:
19660683
8.

Occupational exposure to magnetic fields and the risk of brain tumors.

Coble JB, Dosemeci M, Stewart PA, Blair A, Bowman J, Fine HA, Shapiro WR, Selker RG, Loeffler JS, Black PM, Linet MS, Inskip PD.

Neuro Oncol. 2009 Jun;11(3):242-9. doi: 10.1215/15228517-2009-002. Epub 2009 Feb 20.

9.

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.

Reardon DA, Fink KL, Mikkelsen T, Cloughesy TF, O'Neill A, Plotkin S, Glantz M, Ravin P, Raizer JJ, Rich KM, Schiff D, Shapiro WR, Burdette-Radoux S, Dropcho EJ, Wittemer SM, Nippgen J, Picard M, Nabors LB.

J Clin Oncol. 2008 Dec 1;26(34):5610-7. doi: 10.1200/JCO.2008.16.7510. Epub 2008 Nov 3.

PMID:
18981465
10.

Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.

Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1069-76. doi: 10.1016/j.ijrobp.2008.05.068. Epub 2008 Oct 30.

PMID:
18977094
11.

Oxidative response gene polymorphisms and risk of adult brain tumors.

Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS, Inskip PD.

Neuro Oncol. 2008 Oct;10(5):709-15. doi: 10.1215/15228517-2008-037. Epub 2008 Aug 5.

12.

Genetic variation in insulin-like growth factors and brain tumor risk.

Lönn S, Rothman N, Shapiro WR, Fine HA, Selker RG, Black PM, Loeffler JS, Hutchinson AA, Inskip PD.

Neuro Oncol. 2008 Aug;10(4):553-9. doi: 10.1215/15228517-2008-026. Epub 2008 Jun 18.

13.

Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults.

Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Chanock SJ, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1655-61.

14.

Lead, genetic susceptibility, and risk of adult brain tumors.

Rajaraman P, Stewart PA, Samet JM, Schwartz BS, Linet MS, Zahm SH, Rothman N, Yeager M, Fine HA, Black PM, Loeffler J, Shapiro WR, Selker RG, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2514-20.

15.

A changing paradigm of glioma biology.

Shapiro WR, Shapiro JR.

Hematol Oncol Clin North Am. 2006 Dec;20(6):1171-91.

PMID:
17113458
16.

Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults.

Bluhm EC, Zahm SH, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Inskip PD.

Am J Epidemiol. 2007 Jan 1;165(1):63-71. Epub 2006 Nov 1.

PMID:
17079691
17.

(131)I-chTNT-1/B mAb: tumour necrosis therapy for malignant astrocytic glioma.

Shapiro WR, Carpenter SP, Roberts K, Shan JS.

Expert Opin Biol Ther. 2006 May;6(5):539-45.

PMID:
16610983
18.

Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.

De Roos AJ, Rothman N, Brown M, Bell DA, Pittman GS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.

Neuro Oncol. 2006 Apr;8(2):145-55. Epub 2006 Jan 27.

19.

Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults.

Rajaraman P, Schwartz BS, Rothman N, Yeager M, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Environ Health Perspect. 2005 Sep;113(9):1209-11.

20.

Central nervous system tumors.

Ashby LS, Pueschel JK, Shapiro WR.

Cancer Chemother Biol Response Modif. 2005;22:605-41. Review. No abstract available.

PMID:
16110631
21.

Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients.

Patel SJ, Shapiro WR, Laske DW, Jensen RL, Asher AL, Wessels BW, Carpenter SP, Shan JS.

Neurosurgery. 2005 Jun;56(6):1243-52; discussion 1252-3.

PMID:
15918940
22.

Self-reported electrical appliance use and risk of adult brain tumors.

Kleinerman RA, Linet MS, Hatch EE, Tarone RE, Black PM, Selker RG, Shapiro WR, Fine HA, Inskip PD.

Am J Epidemiol. 2005 Jan 15;161(2):136-46.

PMID:
15632263
23.

Reproductive and hormonal factors and risk of brain tumors in adult females.

Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Int J Cancer. 2005 May 1;114(5):797-805.

24.

Meningioma and schwannoma risk in adults in relation to family history of cancer.

Hill DA, Linet MS, Black PM, Fine HA, Selker RG, Shapiro WR, Inskip PD.

Neuro Oncol. 2004 Oct;6(4):274-80.

25.

Brain tumors.

Pueschel JK, Ashby LS, Shapiro WR.

Cancer Chemother Biol Response Modif. 2003;21:655-81. Review. No abstract available.

PMID:
15338768
26.

Season of birth and risk of brain tumors in adults.

Brenner AV, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.

Neurology. 2004 Jul 27;63(2):276-81.

PMID:
15277620
27.

Low-grade glioma: supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults.

Ashby LS, Shapiro WR.

Curr Neurol Neurosci Rep. 2004 May;4(3):211-7. Review.

PMID:
15102347
28.

Occupation and risk of meningioma and acoustic neuroma in the United States.

Rajaraman P, De Roos AJ, Stewart PA, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Am J Ind Med. 2004 May;45(5):395-407.

PMID:
15095422
29.

Cancer in first-degree relatives and risk of glioma in adults.

Hill DA, Inskip PD, Shapiro WR, Selker RG, Fine HA, Black PM, Linet MS.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1443-8.

30.

Occupation and the risk of adult glioma in the United States.

De Roos AJ, Stewart PA, Linet MS, Heineman EF, Dosemeci M, Wilcosky T, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.

Cancer Causes Control. 2003 Mar;14(2):139-50.

PMID:
12749719
31.

Sociodemographic indicators and risk of brain tumours.

Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Linet MS.

Int J Epidemiol. 2003 Apr;32(2):225-33.

PMID:
12714541
32.

Brain tumors.

Ashby LS, Shapiro WR.

Cancer Chemother Biol Response Modif. 2002;20:575-604. Review. No abstract available.

PMID:
12703225
33.

Handedness and risk of brain tumors in adults.

Inskip PD, Tarone RE, Brenner AV, Fine HA, Black PM, Shapiro WR, Selker RG, Linet MS.

Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):223-5.

34.

Laterality of brain tumors.

Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Selker RG, Fine HA, Black PM, Loeffler JS, Shapiro WR, Linet MS.

Neuroepidemiology. 2003 Mar-Apr;22(2):130-8.

PMID:
12629279
35.

Polio vaccination and risk of brain tumors in adults: no apparent association.

Brenner AV, Linet MS, Selker RG, Shapiro WR, Black PM, Fine HA, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):177-8. No abstract available.

36.

Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors.

De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS, Bell DA.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):14-22.

37.

The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.

Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, Malkin MG, Mealey JJ Jr, Neal JH, Olson J, Robertson JT, Barnett GH, Bloomfield S, Albright R, Hochberg FH, Hiesiger E, Green S; Brain Tumor Cooperative Group.

Neurosurgery. 2002 Aug;51(2):343-55; discussion 355-7.

PMID:
12182772
38.

Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.

Mehta MP, Shapiro WR, Glantz MJ, Patchell RA, Weitzner MA, Meyers CA, Schultz CJ, Roa WH, Leibenhaut M, Ford J, Curran W, Phan S, Smith JA, Miller RA, Renschler MF.

J Clin Oncol. 2002 Aug 15;20(16):3445-53.

PMID:
12177105
39.

History of allergies and autoimmune diseases and risk of brain tumors in adults.

Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Int J Cancer. 2002 May 10;99(2):252-9.

40.

Brain tumors.

Ashby LS, Shapiro WR.

Cancer Chemother Biol Response Modif. 2001;19:653-90. Review. No abstract available.

PMID:
11686038
41.
42.

Cellular-telephone use and brain tumors.

Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS.

N Engl J Med. 2001 Jan 11;344(2):79-86.

43.

Brain tumors.

Ashby LS, Obbens EA, Shapiro WR.

Cancer Chemother Biol Response Modif. 1999;18:498-549. Review. No abstract available.

PMID:
10800500
44.

Current therapy for brain tumors: back to the future.

Shapiro WR.

Arch Neurol. 1999 Apr;56(4):429-32. Review.

PMID:
10199330
45.

Management of primary brain tumors--1996.

Shapiro WR.

Ann N Y Acad Sci. 1997 Dec 19;835:132-41. Review. No abstract available.

PMID:
9616768
46.

Biology and treatment of malignant glioma.

Shapiro WR, Shapiro JR.

Oncology (Williston Park). 1998 Feb;12(2):233-40; discussion 240, 246. Review.

47.

Bias in uncontrolled brain tumor trials.

Shapiro WR.

Can J Neurol Sci. 1997 Nov;24(4):269-70. No abstract available.

PMID:
9398971
48.

Brain tumors.

Obbens EA, Shapiro WR.

Cancer Chemother Biol Response Modif. 1997;17:619-41. Review. No abstract available.

PMID:
9551233
49.

Brain tumors.

Obbens EA, Schneider AG, Shapiro WR.

Cancer Chemother Biol Response Modif. 1996;16:625-43. Review. No abstract available.

PMID:
8639405
50.

Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.

Hiesiger EM, Green SB, Shapiro WR, Burger PC, Selker RG, Mahaley MS Jr, Ransohoff J 2nd, VanGilder JC, Mealey J Jr, Robertson JT, et al.

J Neurooncol. 1995;25(2):143-54.

PMID:
8543970

Supplemental Content

Loading ...
Support Center